Severe side effects in patients with B-cell chronic lymphocytic leukemia (CLL) and lymphocytosis treated with the monoclonal anti-CD20 antibody rituximab.

被引：0
|
作者：
Winkler, U [1 ]
Jensen, M [1 ]
Manzke, O [1 ]
Tesch, H [1 ]
Bohlen, H [1 ]
Diehl, V [1 ]
Engert, A [1 ]
机构：
[1] Univ Cologne, Dept Internal Med 1, Cologne, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4228
引用
收藏
页码：285B / 285B
页数：1
相关论文
共 50 条
  • [1] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [2] Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
    Pickartz, T
    Ringel, F
    Wedde, M
    Renz, H
    Klein, A
    von Neuhoff, N
    Dreger, P
    Kreuzer, KA
    Schmidt, CA
    Srock, S
    Schoeler, D
    Schriever, F
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) : 1410 - 1416
  • [3] Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)
    M. Jensen
    U. Winkler
    O. Manzke
    V. Diehl
    A. Engert
    Annals of Hematology, 1998, 77 : 89 - 91
  • [4] Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)
    Jensen, M
    Winkler, U
    Manzke, O
    Diehl, V
    Engert, A
    ANNALS OF HEMATOLOGY, 1998, 77 (1-2) : 89 - 91
  • [5] Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia
    Pantelidou, D
    Tsatalas, C
    Margaritis, D
    Kaloutsi, V
    Spanoudakis, E
    Bourikas, G
    HEMATOLOGY JOURNAL, 2004, 5 (06) : 546 - 547
  • [6] Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia
    Rawstron, Andy C.
    Bennett, Fiona L.
    O'Connor, Sheila J. M.
    Kwok, Marwan
    Fenton, James A. L.
    Plummer, Marieth
    de Tute, Ruth
    Owen, Roger G.
    Richards, Stephen J.
    Jack, Andrew S.
    Hillmen, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06): : 575 - 583
  • [7] Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
    Mulligan, Christopher S.
    Thomas, Miriam E.
    Mulligan, Stephen P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19): : 2065 - 2066
  • [8] Toxicity and efficacy of the anti-CD20 antibody rituximab (Rituxan™) in patients with B-cell chronic lymphocytic leukemia:: A phase I/II study.
    Winkler, U
    Schulz, HR
    Jensen, M
    Manzke, O
    Rüdiger, T
    Müller-Hermelink, KH
    Diehl, V
    Engert, A
    BLOOD, 1999, 94 (10) : 312A - 312A
  • [9] Retreatment of 11 patients with immune thrombocytopenic purpura with the anti-CD20 monoclonal antibody, rituximab.
    Cooper, N
    Stasi, R
    Michel, M
    Bussel, JB
    BLOOD, 2003, 102 (11) : 86B - 86B
  • [10] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Abou Mourad, Y
    Taber, A
    Chehal, A
    Shamseddine, A
    ANNALS OF HEMATOLOGY, 2004, 83 (05) : 319 - 321
12345